申请人:American Cyanamid Company
公开号:US04603145A1
公开(公告)日:1986-07-29
This disclosure describes novel diaryl-alkanamides. These compounds are useful as pharmaceutical agents for ameliorating atherosclerosis by inhibiting the formation and development of atherosclerotic lesions in the arterial wall of mammals.
这份披露描述了新颖的二芳基-烷酰胺。这些化合物可作为药用剂,通过抑制哺乳动物动脉壁上动脉粥样硬化病变的形成和发展,有助于改善动脉粥样硬化。